Your session is about to expire
← Back to Search
TENS for Eye Pain
Study Summary
This trial will test whether transcutaneous electrical nerve stimulation (TENS) is an effective treatment for ocular pain in veterans with dry eye syndrome.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have a pacemaker, epilepsy, or any condition that prevents TENS use.My medication has not changed in the last 3 months.This criterion does not exclude anyone based on their race or ethnicity. All races and ethnicities are included.I am 18 years old or older.I am either male or female.I have been diagnosed with tear dysfunction.I have had eye pain for at least 6 months.My average eye pain is 4 or higher on a scale of 0 to 10.I have eye conditions like scarring or swelling that cause pain.I have never used TENS for facial pain.I experience eye pain that feels like nerve pain.
- Group 1: Active TENS
- Group 2: Sham TENS
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this trial currently open for enrollment?
"Affirmative, according to information found on clinicaltrials.gov this medical experiment is actively looking for volunteers. It was first listed on October 3rd 2022 and its most recent update occurred on the 7th of that same month. Presently, 50 participants must be sourced from a single location."
How many participants are currently invited to partake in this research?
"Affirmative, according to clinicaltrials.gov this investigation is still recruiting members since its posting on October 3rd 2022 and last edit date of October 7th 2022. The trial seeks 50 individuals at a single site."
Share this study with friends
Copy Link
Messenger